ovarian-cancer

Documents about ovarian-cancer

• Omission of lymphadenectomy in patients with advanced epithelial ovarian cancer treated with primary or interval cytoreductive surgery after neoadjuvant chemotherapy: The CARACO phase III randomized trial.#476018HAL (France)
• Combretastatin A-1 phosphate potentiates the antitumor activity of carboplatin and paclitaxel in a severe combined immunodeficiency disease (SCID) mouse model of human ovarian carcinoma.#644893Lund University Publications
• Menopausal Impact of Opportunistic Salpingectomy for Ovarian Cancer Prevention#847563ClinicalTrials.gov
• Impact of the COVID-19 Pandemic in Gynecological Oncology#882371ClinicalTrials.gov
• Scalable Communication Modalities for Returning Genetic Research Results#905611ClinicalTrials.gov
• A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors#909663ClinicalTrials.gov
• ABT-751 in Treating Young Patients With Refractory Solid Tumors#803060ClinicalTrials.gov
• ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease#955617Koc University Digital Collections
• A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9#888748ClinicalTrials.gov
• Identification of six new susceptibility loci for invasive epithelial ovarian cancer#202825Lund University Publications
• Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial#677111HAL (France)
• Correlation of nutritional status and anxiety with quality of life among ovarian cancer patients undergoing chemotherapy: A cross-sectional study at a provincial referral hospital in Indonesia.#685462NCBI PubMed Central
• Assessing the genetic architecture of epithelial ovarian cancer histological subtypes#612070eScholarship
• APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced ST#836711ClinicalTrials.gov
• Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and Pancreas#909240ClinicalTrials.gov
• Development and Validation of a Multi-Omics Model Integrating US-Derived and WSI-Based Features to Predict Lymph Node Metastasis in Ovarian Cancer: A Multi-Center Retrospective Study.#301630NCBI PubMed Central
• Data-driven modeling in healthcare: From generative AI in healthcare education to epidemiological and ovarian cancer biomarker modeling#348773RUcore, Rutgers University Community Repository
• Guided Imagery in the Perioperative Period in Gynecologic Oncology Patients#868850ClinicalTrials.gov
• Health After eaRly Menopause Due to Oophorectomy#869540ClinicalTrials.gov
• Trial Comparing Simple Follow-up to Exploratory Laparotomy Plus "in Principle" (Hyperthermic Intraperitoneal Chemotherapy) HIPEC in Colorectal Patients#839062ClinicalTrials.gov
• Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members#804368ClinicalTrials.gov
• Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck#873306ClinicalTrials.gov
• Biomarkers of Resiliency In Childhood Cancer Surgery#835320ClinicalTrials.gov
• A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)#162475ClinicalTrials.gov
• Study to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid Tumors#180367ClinicalTrials.gov
• Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial#669976HAL (France)
• Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma#909139ClinicalTrials.gov
• A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.#828040ClinicalTrials.gov
• Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence#843616ClinicalTrials.gov
• A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid Tumors#889138ClinicalTrials.gov
• Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal Mesothelioma#833993ClinicalTrials.gov
• DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors#854313ClinicalTrials.gov
• Development of Genetic Testing Strategies for Hereditary Breast and Ovarian Cancer Risk Prediction by Analysis of Spectrum of Predisposing Mutations and Their Phenotypic Manifestations: Genetic Data#260366Rīga Stradiņš University Institutional Repository Dataverse Dataverse OAI Archive
• A Double-blind Non Inferiority Clinical Trial to Compare the Nephroprotection of Cilastatn Versus Thiosulfate in Patients Undergoing Debulking Surgery With Intraoperative Hyperthermic Intraperitoneal Chemotherapy With Cisplatin.#966175ClinicalTrials.gov
• Development of Genetic Testing Strategies for Hereditary Breast and Ovarian Cancer Risk Prediction by Analysis of Spectrum of Predisposing Mutations and Their Phenotypic Manifestations: Clinical Data#260360Rīga Stradiņš University Institutional Repository Dataverse Dataverse OAI Archive
• Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer#314345ClinicalTrials.gov
• Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers#882356ClinicalTrials.gov
• A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)#909134ClinicalTrials.gov
• {'@classid': 'main title', '@classname': 'main title', '@schemeid': 'dnet:dataCite_title', '@schemename': 'dnet:dataCite_title', '$': 'Explainable Artificial Intelligence based Ensemble Machine Learning for Ovarian Cancer Stratification using Electronic Health Records'}#490973OpenAIRE
• Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives#914106ClinicalTrials.gov
• Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer#875036ClinicalTrials.gov
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer#893633ClinicalTrials.gov
• Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial#887025ClinicalTrials.gov
• An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination With Temozolomide (TMZ) or With Carboplatin and Paclitaxel in Subjects With Advanced Solid Tumors#828514ClinicalTrials.gov
• High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors#857141ClinicalTrials.gov
• SurgiPerito Trial: High-Purity Type-I Collagen for Peritoneal Reconstruction After Cytoreductive Surgery#870166ClinicalTrials.gov
• FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy#491983eScholarship
• Search for Predictors of Therapeutic Response in Ovarian Carcinoma#830237ClinicalTrials.gov
• A Novel Rat Ovarian Cancer Model Developed to Examine Chemotherapy-Related Cognitive Impairments#619887eScholarship
• Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery#893792ClinicalTrials.gov